News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

OncLive TV

Dr. Pearlstone on Current Biomarker Utilization

ByDavid Pearlstone, MD

March 10th 2011

Dr. Pearlstone on Difficult Patient Conversations

ByDavid Pearlstone, MD

March 10th 2011

Laura Metcalfe on Alternative Medicine

ByLaura Metcalfe, MSN, RN

March 8th 2011

Dr. Pearlstone on Practice Changing Studies

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone on Technological Challenges

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone on the John Theurer Cancer Center

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone Describes the Young Cancer Coalition

ByDavid Pearlstone, MD

March 8th 2011

Dr. David Pearlstone, from John Theurer Cancer Center, Describes the Young Cancer Coalition

Emotional and Psychological Side Effects of Chemotherapy

ByLaura Metcalfe, MSN, RN

March 8th 2011

Dr. Perez on her Anticipated Results for ASCO and SABCS

ByEdith A. Perez, MD,

March 8th 2011

Trending on OncLive

Generic Enzalutamide Tablets Granted Tentative FDA Approval for Prostate Cancer

CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy

FDA Approves Prefilled Pen for Ropeginterferon Alfa-2b in Polycythemia Vera

The OncFive: Top Oncology Articles for the Week of 6/21

FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma